top-flor: treatment of newly-diagnosed fl with golcadomide, rituximab /- nivolumab
Published 11 months ago • 174 plays • Length 1:08Download video MP4
Download video MP3
Similar videos
-
2:19
1st flor: nivolumab and rituximab in follicular lymphoma
-
1:29
the evolving treatment landscape of r/r fl & the importance of individualizing treatment approaches
-
2:42
could asciminib be the new breakthrough in the treatment of cml?
-
1:28
a long-term analysis of lenalidomide and rituximab for the treatment of cll
-
1:24
novel agents for the treatment of hodgkin lymphoma: brentuximab vedotin and nivolumab
-
2:21
impact of tmtv on pfs following glofitamab treatment in r/r dlbcl
-
2:41
israeli company on the edge of finding diabetes cure
-
11:36
my six-hour rituxan infusion for autoimmune disease
-
19:23
lymphoma explained clearly - hodgkins & non-hodgkin's pathophysiology
-
2:25
a phase ii adaptive study of dasatinib and inotuzumab-based induction for newly diagnosed ph all
-
2:17
updates on the flt3 inhibitor ff-10101 for the treatment of r/r aml
-
1:55
update on the phase i/ii bruin study
-
0:44
the recent fda approval of ponatinib for ph all following success in the phallcon trial
-
4:20
therapy-related all: etiology, prognosis, and treatment
-
1:19
safety and efficacy of mb-106 for the treatment of r/r fl
-
1:25
targeted therapy for the treatment of follicular lymphoma
-
0:52
a real-world study of the optimal duration of cpx-351 treatment in patients with aml
-
2:25
the safety & efficacy of copanlisib nivolumab in patients with rt and tnhl: a chemo-free approach
-
1:21
cd20/cd3 bispecific antibodies in r/r dlbcl: glofitamab and epcoritamab
-
1:09
emerging treatment options for refractory immune thrombocytopenia
-
0:53
go-flag: bridge therapy to allo-sct in r/r aml